[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +2%
1 Month: XX% +6%
6 Months: XX% +17%
1 Year: XX% +12%
1-Year High: XX% on 2025-06-26
1-Year Low: XX% on 2024-11-24
Most Supportive Themes
- Novavax Collaboration: (35%) Positive news regarding the expansion of the collaboration and license agreement between Novavax and Sanofi, potentially boosting Sanofi's influenza vaccine program.
- Insulin Availability: (15%) Sanofi's initiative to make insulin medications available for $XX a month in the US is viewed positively.
- Oversold Stocks: (10%) Mentions of Sanofi as an oversold stock, suggesting potential for a price increase.
Most Critical Themes
- EU Antitrust Inspection: (10%) An EU antitrust inspection at Sanofi's premises raises concerns about potential legal issues.
- Multinational Exits: (20%) Reports of multinational companies, including those in the pharmaceutical sector, leaving Pakistan due to economic and regulatory challenges.
- Negative Sentiment on X: (20%) A significant portion of engagements on X (Twitter) express negative sentiment towards Sanofi.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXXX | XX% | XXXXXX | XX% | XXXXX | X% |
| TikTok | XXX | X% | XXX | X% | X | X% |
| YouTube | XXXXX | XX% | XXXXX | X% | XXX | X% |
| X | X% | X | X% | X | X% | |
| News | X | X% | X | X% | X | X% |
| Total | XXXXXX | XX% | XXXXXX | XX% | XXXXX | X% |